Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 207-821-5 | CAS number: 496-46-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- not specified
- Qualifier:
- according to guideline
- Guideline:
- other:
- Version / remarks:
- Commision Directive 2000/32/EC, Annex 4C, dated May 19, 2000
- Deviations:
- not specified
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- other: Micronucleus Assay
Test material
- Reference substance name:
- Perhydroimidazo[4,5-d]imidazole-2,5-dione
- EC Number:
- 207-821-5
- EC Name:
- Perhydroimidazo[4,5-d]imidazole-2,5-dione
- Cas Number:
- 496-46-8
- Molecular formula:
- C4H6N4O2
- IUPAC Name:
- perhydroimidazo[4,5-d]imidazole-2,5-dione
- Test material form:
- solid: particulate/powder
1
- Specific details on test material used for the study:
- Batch number: Fixapret 140 Nr. 766.
Date of manufacturing: March 24, 2001.
Purity: 96.3g/100g.
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Details on species / strain selection:
- The mouse is an animal model for which suitable cytogenic investigations have been made, historic data from these investigations aid to elucidate interpretation of results from the micronucleus test. Additionally, the mouse is an experimental animal model that has been traditionally utilised for toxicological studies.
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Test Animals
Strain: NMRI.
Source: RCC Ltd. Biotechnology and Animal Breeding Division; CH-4414 Füllinsdorf.
Number: 42.
Initial age at the start of acclimatisation: 8-10 weeks.
Acclimatisation period: 5 days (minimum).
Body weight at beginning of study: mean value 40.9g (SD± 3.8g).
The animals were distributed into the test groups at random and identified by cage number.
Environmental Conditions
Housing: Single.
Bedding: Granulated soft wood bedding.
Feed: Pelleted standart diet, ad libitum (ALIROMIN 1324, D-32791 Lage/Lippe).
Water: Tap water, ad libitum (Gemeindewerke, D-64380 Roßdorf).
Temperature: 21C (SD± 4C).
Humidity: 30-70%.
Lighting: 12 hours Light / 12 Hours dark.
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- 0.5% carboxymethyl cellulose (CMC).
- Details on exposure:
- Prior to treatment, all animals (including controls) were weighed and the individual volume to be administered was 10mL/kg body weight. The animals were then administered with the test substance, the vehicle or the positive control substance once intraperitoneally.
- Duration of treatment / exposure:
- The animals were sacrified by cervical dislocation 48 hours post test substance administration.
- Frequency of treatment:
- Once.
- Post exposure period:
- 48 hours.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 6.
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Historical positive control(s) were reported using a known clastenogestic and aneugenic substance; cyclophosphamide; 40 mg/kg b.w (oral administration).
Micronucleated polychromatic erythrocytes per thousand;
Range: 10.00 to 27.10.
Mean: 16.53*±4.09 (*= mean of 35 experiments (caiculated from 350 animals; 2000 polychromatic erythrocytes scored per animal).
Examinations
- Tissues and cell types examined:
- Bone marrow.
- Details of tissue and slide preparation:
- The femora were removed, the epiphyses were cut off and the marrow was flushed out with fetal calf serum, using a syringe. The cell suspension was centrifuged at 1500 rpm (390 x g) for 10 minutes and the supernatant was discarded. A small drop of the resuspended cell pellet was spread on a slide. The smear was air-dried and then stained with May-Grunwald (MERCK, D-64293Darmstadt)/Giemsa (Gurr, BDH Limited Poole, Great Britain). Cover slips were mounted with EUKITT (KINDLER, D-79110 Freiburg). At least one slide was made from each bone marrow sample.
- Evaluation criteria:
- The test substance is classified as mutagenic if;
- it induces either a dose-related increase in the number of micronucleated polychromatic erythrocytes, that is statistically significant when compared with the negative control range or a relevant positive response for at least one of the test points.
The test substance is considered non-mutagenic if;
- neither a dose-related increase in the number of micronucleated polychromatic erythrocytes nor a positive response at any of the test points. - Statistics:
- Evaluation via statistical method analysis was conducted using a non-parametric Mann-Whitney test.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
Summary of Micronucleus Test Results
Test group |
dose mg/kgb.w. |
sampling time (h) |
PCEs with micronuclei (%) |
Range |
PCE/ NCE ratio |
vehicle |
0 |
24 |
0.50 |
0-2 |
2000/1819 |
test substance |
500 |
24 |
1.00 |
0-5 |
2000/1953 |
test substance |
1000 |
24 |
0.30 |
0-2 |
2000/2597 |
test substance |
2000 |
24 |
0.40 |
0-2 |
2000/2377 |
positive control |
40 |
24 |
19.20 |
25-52 |
2000/1866 |
vehicle |
0 |
48 |
0.60 |
0-2 |
2000/1699 |
test substance |
2000 |
48 |
0.70 |
0-4 |
2000/2429 |
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of the study, it is concluded that the test substance did not cause any clastenogenic or aneugenic effects on the test animals.
- Executive summary:
The study aimed to investigate the potential of the test substance glycoluril to introduce micronucleus abnormalities in polychromatic erythrocytes (PCE) in the bone marrow of the mouse according to the OECD Guideline No 475 (1997) and the Commission Directive 2000/32/EC, Annex 4C (2000).
The test substance was dissolved in 0.5% CMC. 10mLkg body weight was administered intraperitoneally 24 hours, and 48 hours after a single administration of the test substance. The bone marrow cells were collected for micronuclei analysis. 5 male mice per test group were evaluated for the occurrence of micronuclei, and at least 2000 PCEs per animal were scored for the presence of micronuclei. The mice were treated with 1000 and 2000 mg/kg b.w. at the 24 hour preparation interval and 2000 mg/kg b.w. at the 48 hour preparation interval. 40 mg/kg b.w. cyclophosphamide administered intraperitoneally was used as a positive control. This showed a substantial increase of induced micronucleus frequency.
At the 48 hour preparation interval, there were slightly increased mean normochromatic erythrocytes (NCE) numbers, as compared to the mean values of NCEs of the corresponding vehicle control. This indicated that glycoluril had cytotoxic effectiveness in the bone marrow. However, when comparing with the corresponding vehicle controls, there was no enhancement in the frequency of the detected micronuclei at any preparation interval after administration of the test substance and with any dose level used.
Therefore, it can be stated that under the experimental conditions reported, the test substance did not induce micronuclei as determined by the micronucleus test with bone marrow cells of the mouse. Thus, glycoluril is considered to be non-clastogenic and non-aneugenic in this micronucleus assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.